发明名称 |
Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders |
摘要 |
The present invention relates to substituted fused heterocyclic compounds. The substituted fused heterocyclic compounds are GPR1 19 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of substituted fused heterocyclic compounds as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them. |
申请公布号 |
AU2015239021(A1) |
申请公布日期 |
2016.10.13 |
申请号 |
AU20150239021 |
申请日期 |
2015.04.02 |
申请人 |
Sanofi |
发明人 |
Schwink, Lothar;Buning, Christian;Glombik, Heiner;Gossel, Matthias;Kadereit, Dieter;Halland, Nis;Lohmann, Matthias;Poverlein, Christoph;Ritter, Kurt |
分类号 |
C07D231/56;A61K31/416;A61K31/4192;A61K31/4745;A61P3/00;C07D249/18;C07D471/04 |
主分类号 |
C07D231/56 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|